Fig. 1From: Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cellsCell viability after 72-h treatment with increasing doses of rapamycin, everolimus and carboplatin. Cell viability was measured by the crystal violet assay as described in the methods section. The error bars represent mean +/− SD of 3 experiments conducted in technical triplicate. IC50, half-maximal inhibitory concentration; mTOR, mechanistic target of rapamycinBack to article page